Crinetics Pharmaceuticals CRNX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's total liabilities?
- Crinetics Pharmaceuticals (CRNX) reported total liabilities of $120.68M in Q1 2026.
- How has Crinetics Pharmaceuticals's total liabilities changed year-over-year?
- Crinetics Pharmaceuticals's total liabilities increased by 12.4% year-over-year, from $107.33M to $120.68M.
- What is the long-term trend for Crinetics Pharmaceuticals's total liabilities?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's total liabilities has grown at a 56.0% compound annual growth rate (CAGR), from $14.53M to $134.17M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.